Beta Bionics, Inc. (BBNX) stock — the fundamentals (P/E, market cap, valuation) and every material event, decoded in plain English.
Key numbers for Beta Bionics, Inc. (BBNX): P/E ratio, market cap, profit margins, returns, and whether the stock looks cheap or expensive versus its own 5-year range.
AllSight quality score: 45/100 — a percentile rank of Beta Bionics, Inc.’s fundamentals against Manufacturing peers, weakest on profitability. A quality ranking, not a price prediction.
| Market cap | $1.0B |
| P / S | 8.6× |
| EV / EBITDA | -12.1× |
| Gross margin | 58.3% |
| Operating margin | -69.8% |
| Net margin | -61.3% |
| Return on equity | -28.5% |
| ROIC | -39.1% |
| Debt / equity | 0.0× |
| Dividend yield | 0.0% |
Independent of the events above — derived from Beta Bionics, Inc.’s own financial statements and shown as context, never as advice.
About AllSight · Editorial standards & method · Contact